Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments

C Papagno, L Trojano - Neurological Sciences, 2018 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by
motor symptoms such as rigidity, rest tremor, and bradykinesia. However, a growing body of …

[HTML][HTML] The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration

L Passamonti, CJ Lansdall, JB Rowe - Current opinion in behavioral …, 2018 - Elsevier
Highlights•Apathy and impulsivity are common consequences of frontotemporal lobar
degeneration syndromes.•Common frontostriatal loops mediate different modes of apathy …

Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans

N Skandali, JB Rowe, V Voon, JB Deakin… - …, 2018 - nature.com
Serotonin is implicated in multiple executive functions including goal-directed learning,
cognitive flexibility, response inhibition and emotional regulation. These functions are …

[HTML][HTML] Activity and connectivity differences underlying inhibitory control across the adult life span

KA Tsvetanov, Z Ye, L Hughes, D Samu… - Journal of …, 2018 - Soc Neuroscience
Inhibitory control requires precise regulation of activity and connectivity within multiple brain
networks. Previous studies have typically evaluated age-related changes in regional activity …

Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia

LE Hughes, T Rittman, TW Robbins, JB Rowe - Brain, 2018 - academic.oup.com
The distribution of pathology in frontotemporal dementia is anatomically selective, to distinct
cortical regions and with differential neurodegeneration across the cortical layers. The …

The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks

C Vriend - Cell and tissue research, 2018 - Springer
Impulse control disorders (ICD) are common neuropsychiatric disorders that can arise in
Parkinson's disease (PD) patients after commencing dopamine replacement therapy …

Effects of antiparkinson medication on cognition in Parkinson's disease: a systematic review

MA Roy, M Doiron, J Talon-Croteau… - Canadian Journal of …, 2018 - cambridge.org
Objective: This study aimed to systematically review the effects of currently prescribed
antiparkinson medication on cognition in patients with mild-to-moderate Parkinson's disease …

Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease

P Manza, G Schwartz, M Masson, S Kann… - Neurobiology of …, 2018 - Elsevier
Dopaminergic medications improve the motor symptoms of Parkinson's disease (PD), but
their effect on response inhibition, a critical executive function, remains unclear. Previous …

Disruption of multiple distinctive neural networks associated with impulse control disorder in Parkinson's disease

P Filip, P Linhartová, P Hlavatá, R Šumec… - Frontiers in Human …, 2018 - frontiersin.org
The phenomenon of impulsivity in Parkinson's disease appears as an arduous side effect of
dopaminergic therapy with potentially detrimental consequences for the life of the patients …

Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease

SA Wylie, NC van Wouwe, SG Godfrey, PG Bissett… - Neuropsychologia, 2018 - Elsevier
The present behavioral study delineates the impact of Parkinson's disease (PD) and of
dopaminergic medication on action control over voluntary behavior. Previous studies …